Advertisement
YOU ARE HERE: LAT HomeCollectionsBrca2
IN THE NEWS

Brca2

NEWS
May 14, 2013 | By Jon Healey
It's hard to imagine Supreme Court justices paying much attention to the travails of Hollywood's rich and famous. Still, there's an interesting connection between Angelina Jolie's disclosure Tuesday that she underwent a double mastectomy and a case the court is deliberating, the Assn. for Molecular Pathology vs. Myriad Genetics . At issue is whether a human gene sequence can be patented. That's the broad question. The two specific sequences patented by Myriad -- BRCA1 and BRCA2 -- are genes that suppress tumors . A small percentage of women have defective copies of those genes, and they are extremely likely to develop a virulent form of breast cancer.
Advertisement
SCIENCE
May 14, 2013 | By Anna Gorman
Late Monday night, friends and colleagues started sending me Angelina Jolie's op-ed about her decision to have a double mastectomy. Like Jolie, I have the mutation in my BRCA1 gene that pushed my lifetime risk of developing breast cancer to nearly 90%. (It also raised my risk of ovarian cancer above 50%.) Also like Jolie, I chose to get a double mastectomy to reduce my risk of breast cancer to less than 5%. In 2007, I wrote a first-person story in the Los Angeles Times about finding out I had this mutation and how I decided what to do about it. Jolie is an icon of beauty -- and her disclosure doesn't change that.
HEALTH
October 1, 2011 | By Jill U. Adams, Special to the Los Angeles Times
What's the case for environmental pollutants contributing to breast cancer? Circumstantial evidence keeps patients, doctors, advocates and scientist asking this question, but so far no clear relationship between exposure and disease has been shown in people. Known risks for breast cancer include family history, mutations in the BRCA1 and BRCA2 genes, a woman's reproductive history — the age at which she gets her first period, the number of children she has and when she enters menopause — and lifestyle factors such as cigarette and alcohol use, diet and exercise.
NEWS
October 1, 1996 | From Times Staff and Wire Reports
Two studies published in the October issue of Nature Genetics indicate that about 1 in 100 Jewish women of Eastern European descent, or about four times as many as previously thought, harbors a specific genetic mutation that increases her risk of breast and ovarian cancer. The gene in question, called BRCA2, is almost never mutated in other ethnic groups and is unrelated to a gene called BRCA1, which also increases the risk of breast and ovarian cancer.
SCIENCE
April 3, 2004 | From Times Staff and Wire Reports
Scientists have completed the final analysis of two more human chromosomes. Chromosome 19 with nearly 1,500 genes, including some linked to high cholesterol and insulin-resistant diabetes, is the most gene-dense of those sequenced. By contrast, chromosome 13 has one of the lowest concentrations of genes with only 633. But they include the BRCA2 gene linked to breast cancer and others linked to bipolar disorder and schizophrenia.
HEALTH
September 20, 2004 | Reuters
Women with a high genetic risk for breast cancer run a better chance of having it detected with magnetic resonance imaging than with mammography and other methods, researchers have reported. The kind of breast cancer involved is caused by mutations of the genes BRCA1 and BRCA2, believed responsible for 5% to 10% of all breast cancer cases. Women with the mutations have a significantly higher risk of breast cancer.
CALIFORNIA | LOCAL
August 13, 1998
Birth control pills appear to halve the chances of ovarian cancer among women with a faulty gene that puts them at high risk for the disease. The pill has long been known to reduce the risk of this kind of cancer among women in general. But until now, it was not clear whether the pill helped those whose risk resulted from bad genes, called BRCA1 and BRCA2. Dr. Steven A.
SCIENCE
November 26, 2003 | From Reuters
Researchers reported Tuesday that they have finally linked inherited forms of breast cancer with seemingly random cases, and said their findings shed more light on the causes of the disease. They found a protein that may disrupt the BRCA1 and BRCA2 genes that cause an inherited form of breast cancer. It may explain why some patients who do not have mutations of these genes get breast cancer.
Los Angeles Times Articles
|